Journal of the American Society of Hypertension
Volume 3, Issue 4 , Pages 267-276 , July 2009

A narrative review of clinical inertia: focus on hypertension

  • Claudio Faria, PharmD, MPH

      Affiliations

    • University of Massachusetts Medical School, Commonwealth Medicine – Clinical Pharmacy Services, Shrewsbury, Massachusetts, USA
    • Corresponding Author InformationCorresponding author: Claudio Faria, PharmD, MPH, University of Massachusetts Medical School, Clinical Pharmacy Services, 333 South Street, Shrewsbury, Massachusetts 01545. Tel: 617-886-8175; fax: 877-208-7428.
    • ,
  • Marie Wenzel, PharmD, BCPS

      Affiliations

    • University of Massachusetts Medical School, Commonwealth Medicine – Clinical Pharmacy Services, Shrewsbury, Massachusetts, USA
    • ,
  • Karen W. Lee, PharmD, BCPS

      Affiliations

    • University of Massachusetts Medical School, Commonwealth Medicine – Clinical Pharmacy Services, Shrewsbury, Massachusetts, USA
    • ,
  • Karen Coderre, PharmD, BCPP

      Affiliations

    • University of Massachusetts Medical School, Commonwealth Medicine – Clinical Pharmacy Services, Shrewsbury, Massachusetts, USA
    • ,
  • Jake Nichols, PharmD, MBA, BCPS

      Affiliations

    • University of Massachusetts Medical School, Commonwealth Medicine – Clinical Pharmacy Services, Shrewsbury, Massachusetts, USA
    • ,
  • Daniel A. Belletti, MA

      Affiliations

    • HEOR/Managed Markets Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Received 17 December 2008 ,Accepted 1 March 2009.

References 

  1. Ruzicka M, Leenen FHH. Moving beyond guidelines: are report cards the answer to high rates of uncontrolled hypertension?. Curr Hypertens Rep. 2006;8:324–329
  2. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, et al. Clinical inertia. Ann Intern Med. 2001;135:825–834
  3. O'Connor PJ. Overcome clinical inertia to control systemic blood pressure. Arch Intern Med. 2003;163:2677–2678
  4. Petty DR, House A, Knapp P, Raynor T, Zermansky A. Prevalence, duration, and indications for prescribing anti-depressants in primary care. Age Aging. 2006;35:523–526
  5. Okonofua ED, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension. 2006;47:345–351
  6. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001;285:182–189
  7. In:  Kohn LT,  Corrigan JM,  Donaldson MS editor. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000;
  8. National Coordinating Council for Medication Error Reporting and Prevention. NCC MERP index for categorizing medications error. Available online: www.nccmerp.org. Accessed: September 18, 2008.
  9. Safford MM, Shewchuck R, Qu H, Williams JH, Estrada CA, Ovalle F, et al. Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care. J Gen Intern Med. 2007;22:1648–1655
  10. O'Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Biltz G. Clinical inertia and outpatient medical errors. Adv Patient Safety. 2005;2:293–308
  11. Grant RW, Wald JS, Poon EG, Schnipper JL, Gandhi TK, Volk LA, et al. Design and implementation of a web-based patient portal linked to an ambulatory care electronic health record: patient gateway for diabetes collaborative care. Diabetes Technol Ther. 2006;8:576–586
  12. O'Connor PJ. Commentary—improving diabetes care by combating clinical inertia. Health Serv Res. 2005;40:1854–1861
  13. Rondondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144:475–484
  14. Nau D, Mallya U. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. Am J Manage Care. 2005;11:69–73
  15. Kiberd J, Panek R, Kiberd B. Strategies to reduce clinical inertia in hypertensive kidney transplant recipients. BMC Nephrol. 2007;8:10;Available from: http://www.biomedcentral.com/1471-2369/8/10. Accessed: March 16, 2009
  16. Grant R, Cagliero E, Dubey A, Gildesgame C, Chueh HC, Barry MJ, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabetic Med. 2004;21:150–155
  17. Knecht L, Gauthier S, Castro JC, Schmidt RE, Whitaker MD, Zimmerman RS, et al. Diabetes care in the hospital: is there clinical inertia?. J Hosp Med. 2006;1:151–160
  18. Cook C, Castro J, Schmidt R, Gauthier SM, Whitaker MD, Roust LR, et al. Diabetes care in hospitalized noncritically ill patients: more evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007;2:203–211
  19. Rondondi N, Peng T, Karter A, Bauer D, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144:475–484
  20. Nau D, Mallya U. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. Am J Manage Care. 2005;11:69–73
  21. Grant R, Cagliero E, Dubey A, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabetic Med. 2004;21:150–155
  22. Knecht L, Gauthier S, Castro J, et al. Diabetes care in the hospital: is there clinical inertia?. J Hosp Med. 2006;1:151–160
  23. Cook C, Castro J, Schmidt R, et al. Diabetes care in hospitalized noncritically ill patients: more evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007;2:203–211
  24. Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007;49:69–75
  25. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control-continued disparities in adults: United States, 2005–2006. NCHS Data Brief, No. 3, 2008.
  26. Andrade S, Gurwitz J, Field T, Kelleher M, Majumdar S, Reed G, et al. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manage Care. 2004;10:481–486
  27. Berlowitz D, Ash A, Hickey E. Hypertension management in patients with diabetes. Diabetes Care. 2003;26:355–359
  28. Berlowitz D, Ash A, Hickey E, Friedman R, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–1963
  29. Holland N, Segraves D, Nnadi V, Belletti D, Wogen J, Arcona S. Identifying barriers to hypertension care: implications for quality improvement initiatives. Disease Manage. 2008;11:71–77
  30. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 1999;34:267–72.
  31. Rose AJ, Shimada SL, Rothendler JA, Reisman JI, Glassman PA, Berlowitz DR, et al. The accuracy of clinician perceptions of “usual” blood pressure control. J Gen Intern Med. 2007;23:180–183
  32. Sever PS. Blood pressure control for the hypertensive patient: what can we do better?. Am J Hypertens. 1997;10:128S–30
  33. Materson BJ, Reda DJ, Cushman WC, Henderson WG. Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Hum Hypertens. 1995;9:791–796
  34. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Anti-Hypertensive Agents. N Engl J Med. 1993;328:914–921
  35. Freis ED. Improving treatment effectiveness in hypertension. Arch Intern Med. 1999;159:2517–2521
  36. Kottke TE, Solberg LI, Brekke ML, Cabrera A, Marquez MA. Delivery rates for preventative services in 44 midwestern clinics. Mayo Clin Proc. 1997;72:515–523
  37. Solberg LI, Brekke ML, Kottke TE, Steel RP. Continuous quality improvement in primary care: what's happening?. Med Care. 1998;36:625–635
  38. Law M, Wald N, Morris J. Lowering-blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess. 2003;7:
  39. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the U.S. adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305–313
  40. Giese M, Lackland DT, Basile J, Egan BM. 2003 update on the Hypertension initiative of South Carolina. Bringing South Carolina from “worst to first” in cardiovascular health. J S C Med Assoc. 2003;99:157–161
  41. Fahey T, Schroeder K, Ebrahim S. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database of Systematic Reviews. 2006;Issue 4. Art. No.: CD005182
  42. O'Connor PJ, Sperl-Hilton JM, Johnson PE, Rush WA, Blitz G. Clinical Inertia and Outpatient Medical Errors. In:  Henriksen K,  Battles JB,  Marks ES,  Lewin DI editor. Advances in Patient Safety: From Research to Implementation. Vol. 2. Concepts and Methodology. Rockville, Maryland: Agency for Healthcare Research and Quality; 2005;
  43. Keating NL, Green DC, Kao AC, Gazmararian JA, Wu VY, Cleary PD. How are patients' specific ambulatory care experiences related to trust, satisfaction, and considering changing physicians?. J Gen Intern Med. 2002;17:29–39
  44. Valenti WM, Voisine R. Academic detailing: questions and answers. AIDS Reader. 2008;18:1–3
  45. Rehman SU, Hutchinson FN, Okonofua EC, Hendrix K, Egan BM. Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites. Arch Intern Med. 2005;165:1041–1047
  46. Phillips LS, Ziemer DC, Doyle JP, Barnes CS, Kolm P, Branch W, et al. An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site. Diabetes Care. 2005;28:2352–2360
  47. Ziemer D, Doyle J, Barnes C, Branch W, Cook C, El-Kebbi I, et al. An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: improving primary care of African Americans with diabetes (IPCAAD) 8. Arch Intern Med. 2006;166:507–513
  48. Dutta P, Biltz GR, Johnson PE, Sperl-Hillen JM, Rush WA, Duncan JE, et al. SimCare: A Simulation Model to Investigate Physician Decision-Making Activity. In:  Henriksen K,  Battles J,  Marks E,  Lewin DI editor. Advances in Patient Safety: From Research to Implementation. Vol. 4. Rockville, Maryland: Agency for Healthcare Research and Quality; 2005;
  49. Snipper JL, Lidner JA, Palchuk MB, Einbinder JS, Postilnik A, Middleson B. “Smart forms” in an electronic medical record: documentation-based clinical decision support to improve disease management. J Am Med Inform Assoc. 2008;15:513–523
  50. Grimshaw JM, Eccles MP, Walker AE, Thomas RE. Changing physicians' behavior: what works and thoughts on getting more things to work. J Cont Educ Health Professions. 2002;22:237–243
  51. Pennsylvania's Independent Drug Information Service. Available at: www.rxfacts.org. Accessed: September 8, 2008.
  52. Simon SR, Majumdar SR, Prosser LA, Salem-Schatz S, Warner C, Kleinman K, et al. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. Am J Med. 2005;118:521–528
  53. Hennessey S, Leonard CE, Yang W, Kimmel SE, Townsend RR, Wasserstein AG, et al. Effectiveness of a two-part educational intervention to improve hypertension: a cluster-randomized trial. Pharmacotherapy. 2006;26:1342–1347
  54. Ara S. A literature review of cardiovascular disease management programs in managed care populations. JMCP. 2004;10:326–344
  55. Figar S, Waisman G, Gonzalez Bernaldo de Quiros R, Galarza G, Marchetti M, Rodrigues Loria G, et al. Narrowing the gap in hypertension: effectiveness of a complex antihypertensive program in the elderly. Dis Manage. 2004;7:235–243
  56. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control. JAMA. 2008;299:2857–2867

 This study was supported by a Grant from Novartis Pharmaceuticals.

 Conflict of interest: none.

PII: S1933-1711(09)00035-7

doi: 10.1016/j.jash.2009.03.001

Journal of the American Society of Hypertension
Volume 3, Issue 4 , Pages 267-276 , July 2009

Article Tools